MIGS refers to a group of newer glaucoma surgeries designed to lower intraocular pressure (IOP) with less trauma to the eye compared to traditional surgeries like trabeculectomy. MIGS procedures are typically minimally invasive, safer, faster recovery, and have very few complications. MIGS can often be combined with cataract surgery in the same sitting or can be done as a stand-alone procedure.
These procedures aim to slow glaucoma progression by lowering IOP — they cannot restore lost vision. MIGS is most suitable for patients with early to moderate glaucoma, especially those who are allergic to topical anti-glaucoma medications or unable to self-administer eye drops.
MIGS can reduce the need for glaucoma drops but may not eliminate them. Lifelong monitoring is still necessary even if IOP is controlled after surgery. MIGS procedures have a success rate of 60–80% in achieving significant IOP reduction, especially when combined with cataract surgery.
While the pressure-lowering effect is generally less dramatic than traditional trabeculectomy, the safety profile and faster recovery make MIGS a valuable option for many patients. Complications can still occur, including Bleeding in the eye (hyphema), transient eye pressure spikes, malposition or blockage of the stent, failure of the device leading to inadequate pressure control & rarely, infection or persistent inflammation.
Narayana Nethralaya
Customer Support
Narayana Nethralaya
Hello, how can I help you today?